Latest news
Loading news…
OraTech Pharmaceuticals
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 High growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Founded 2025 For Profit
OraTech Pharmaceuticals centralize the development and commercialization of Protein Oral Delivery (POD™) technology.
OraTech Pharmaceuticals on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
OraTech Pharmaceuticals was acquired by Lifeward in 2026.
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0
About OraTech Pharmaceuticals
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Founded
- 2025
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 1
- Exit date
- Mar 26, 2026
Signals & Scores
- Heat score
- Low
- Growth score
- High
- Trend (7d)
- 5.6
- Trend (30d)
- 7.1
- Trend (90d)
- -3.7
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to OraTech Pharmaceuticals
Loading news…
FAQs about OraTech Pharmaceuticals
People who checked this page also checked these
Browse the full Acquirezy directory.